Many VSL3 Research Studies have been conducted with very positive outcomes. VSL#3 reseach studies show how VSL probiotics can be used to help people with Irritable Bowel Syndrome, Ulcerative Colitis, and Pouchitis, i.e. inflammation of the ileal pouch.
It is also encouraging to note that VSL3 probiotics research studies show that VSL is also effective in helping children. Both the American Academy of Pediatrics and The European Society of Pediatric Gastroenterology Hepatology and Nutrition have published studies.
- Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.
- Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea.
- Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
- Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial.
- Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation.
- Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.
- Probiotics promote gut health through stimulation of epithelial innate immunity.
Reputable Institutions have conducted VSL3 research studies and endorse the efficacy of VSL#3 probiotics.
The Cochrane Library:
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
The American College of Gastroenterology
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.
The American Academy of Pediatrics.
Clinical Report—Probiotics and Prebiotics in Pediatrics
The European Society of Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines.
The World Organization of Gastroenterology.
WGO Practice Guideline – Irritable Bowel Syndrome (IBS)